Todd Verdoorn Net Worth & Insider Trades
Todd Verdoorn - Chief Scientific Officer, Diamedica Therapeutics Inc
What is Todd Verdoorn's Net Worth?
The current estimated net worth of Diamedica Therapeutics Inc's Chief Scientific Officer, Todd Verdoorn, is estimated to be about $8.44K . Todd Verdoorn owns about 2,000 units of Diamedica Therapeutics Inc common stock. In the last year at Diamedica Therapeutics Inc, Todd Verdoorn has sold an estimated value of $0 worth.
What is Todd Verdoorn's Past Insider Trading?
Todd Verdoorn's largest purchase order was 1,000 units , worth over $4K on December 11, 2018. In total, Todd Verdoorn has made about 2 transactions over a year of their time at Diamedica Therapeutics Inc. Todd Verdoorn usually trades in June and December, with the busiest year in 2019 and 2018.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Todd Verdoorn
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Todd Verdoorn's' Mailing Address?
- Mailing address is 2 Carlson Parkway Suite 260 Minneapolis MN 55447 MN
Diamedica Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Rick Pauls | 2020 | $455,013 | - | $190,624 | $217,716 | $14,850 | $878,203 |
| Rick Pauls | 2019 | $420,000 | - | $890,736 | $178,000 | $14,650 | $733,707 |
| Scott Kellen | 2020 | $276,075 | - | $119,140 | $79,238 | $14,850 | $489,303 |
| Scott Kellen | 2019 | $262,500 | - | $336,557 | $64,800 | $13,950 | $677,807 |
| Harry Alcorn, Jr., Pharm.D. | 2020 | $291,413 | - | $119,140 | $83,662 | $14,850 | $509,065 |
| Harry Alcorn, Jr., Pharm.D. | 2019 | $273,750 | - | $421,750 | $68,400 | $14,400 | $778,300 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1401040/000143774921014066/dmtp20210406_def14a.htm
What are Diamedica Therapeutics Inc's Past Insider Trades?
Diamedica Therapeutics Inc's most recent insider trade came on June 27, 2023 by Thomas Koch von, Ab Tomenterprise and Ab Private Tomeqt who bought 1,470,588 units worth $5M . In the last 5 years, insiders at Diamedica Therapeutics Inc have sold an estimated value of $3.53M and bought an estimated value of $11.97M worth of shares. Insider trading is most common in June, with the busiest year in 2023. The most active traders at the company are Michael Randall Giuffre, Director, Richard Pilnik, Director, and Scott Kellen, CFO and Secretary .
DiaMedica Therapeutics Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||